The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder

Published:2015-09-25 Issue:3 Volume:14 Page:307-308
ISSN:1723-8617
Container-title:World Psychiatry
language:en
Short-container-title:World Psychiatry

Author:

Fava Maurizio¹

Affiliation:

1. Clinical Trials Network and Institute (CTNI); Massachusetts General Hospital and Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Phychiatric Mental Health

Reference11 articles.

1. Antidepressants versus placebo in major depression: an overview;Khan;World Psychiatry,2015

2. Massachusetts General Hospital SAFER criteria for clinical trials and research;Desseilles;Harv Rev Psychiatry,2013

3. Assuring that double-blind is blind;Perlis;Am J Psychiatry,2010

4. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis;Tedeschini;Eur Neuropsychopharmacol,2010

5. Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant;Laughren;J Clin Psychiatry,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents;World Psychiatry;2023-01-14

2. Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders;Neuropsychopharmacology;2020-11-26

3. Why are new antidepressants failing to make the grade for approval?;Expert Opinion on Pharmacotherapy;2017-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3